The authors regret that in the Results section of the Abstract in the original publication, the number of KRAS-wt patients was incorrectly given. The correct Abstract should read as follows:
Corrigendum to “Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population”
Annals of Oncology | | J.F. Seligmann, D. Morton, F. Elliott, K. Handley, R. Gray, M. Seymour, B. Glimelius, L. Magill, C.J.M. Williams, P. Quirke, D. Bottomley, H.M. Wood, K. Murakami, A.D. Beggs, N.P. West, FOxTROT Collaborative Group
Topics: colorectal-cancer, blood-cancer, targeted-therapy, clinical-trials, research